Effect of intraarticular injection of lornoxicam on the articular cartilage & synovium in rat.
نویسندگان
چکیده
BACKGROUND & OBJECTIVE Intraarticular (i.a) drug application is consider to be a new therapeutic approach for the treatment of postoperative pain after arthroscopic knee surgery without any systemic adverse effects. Lornoxicam, a nonsteroid anti-inflammatory drug is a short acting agent, and its anti-inflammatory and analgesic activity may be effective in the postoperative pain management in minor surgery. In this study, the effects of intraarticular administration of lornoxicam on the synovium and articular cartilage in the rat knee joint were investigated. METHODS Lornoxicam (0.25 ml) was given as an injection into the right knee joint and 0.25 ml of 0.9 per cent saline solution by injection into the left knee joint as a control in 25 rats. Groups of five rats were sacrificed by a lethal injection of ketamine 1st, 2nd, 7th, 14th and 21st days after lornoxicam administration. Knee joints were detached, fixed in 10 per cent buffered formalin and decalcified. Serial sections of 5 microm were stained with haematoxylin-eosin and evaluated for the presence of inflammation in the articular, periarticular regions and synovium. Inflammatory changes in the joints were graded according to a five-point scale, histologically. RESULTS There were no significant differences in inflammation and cartilage degeneration, between control and lornoxicam applied knees. Grade 3 inflammatory changes occurred only in one knee in lornoxicam group, at 24 h after injection. No pathological changes were observed in both groups at any time point. INTERPRETATION & CONCLUSION Lornoxicam did not show significant effect on inflammation on rat synovia in knee joint. Further studies including in human need to be done before any recommendations are made for i.a. administration of lornoxicam.
منابع مشابه
Effect of Intraarticular Ketamine Administration on the Histopathological Changes of Knee Joint in the Rat Model
Objective- Postoperative pain management in patients that undergone arthroscopy is one of the most important procedures for their rehabilitation. Analgesic injection intra-articularly can facilitate pain control in such patients. The aim of this study was to evaluate the effects of ketamine on articular cartilage in rat model. Design- Experimental study. Animals- Twenty Wistar Rats Procedure...
متن کاملThe Effect of Intra-Articular Magnesium on the Articular Cartilage and Synovium in the Rat Knee Joint
Objective: Magnesium sulfate has been shown to provide analgesia when administered into the knee joints. The aim of this study was to evaluate the histopathological effects of intraarticular administration of magnesium sulfate in the rat knee joint. Design: A total of 50 rats were given 0.25ml of magnesium sulfate (10%) by injection into the right knee joint and 0.25ml of 0.9% saline solution b...
متن کاملThe Effect of Mesenchymal Stem Cells and Aqueous Extract of Elaeagnus Angustifolia on the Mechanical Properties of Articular Cartilage in an Experimental Model of Rat Osteoarthritis
Introduction: Although, the effect of direct intra-articular injection of bone marrow stem cells (BMSCs) on the repair of articular cartilage and the effect of Elaeagnus angustifolia extract on pain relief in patients with osteoarthritis have been investigated, no studies has been conducted to compare the effects of these two therapeutic methods on the mechanical properties of articular cartila...
متن کاملComparison of intraarticular bupivacaine and levobupivacaine injection in rat synovial inflammation.
BACKGROUND/AIM Both bupivacaine and levobupivacaine are local anesthetics with strong analgesic efficacy that can be used intraarticularly. The aim of this study was to compare the effects of intraarticular bupivacaine and levobupivacaine injection on inflammation in articular cartilage and the synovium of the rat knee joint. MATERIALS AND METHODS Twenty Sprague-Dawley rats were injected in t...
متن کاملChitosan Temperature-Sensitive Gels: Reduce the Burst Release of Microspheres Containing Lornoxicam and Enhance Drug Targeting
Lornoxicam (Lnxc), a novel type of non-steroidal antiinflammatory drug developed by comely, was first listed in Denmark in October 1997 (trade name xefo). Clinically, it is used to treat rheumatoid, rheumatoid arthritis and osteoarthritis. The Lnxc with low drug concentration has a short half-life [1] after oral administration, leading to much side effect and therapy activity tended to be worse...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Indian journal of medical research
دوره 127 4 شماره
صفحات -
تاریخ انتشار 2008